Status: Recruiting
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy of chemoradiotherapy combined with immunotherapy.
Participants needed: 50
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Sun Yat-sen UniversityUpdated: May 11, 2026Locations: 1
Eligibility criteria
Recurrent or metastatic nasopharyngeal carcinoma patients [+3]
Have or are suffering from other malignant tumors; [+6]